David Mokler News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from David mokler. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In David Mokler Today - Breaking & Trending Today
This article by Gaurav Dubey was originally published on Microdose Psychedelic Insights and appears here with permission. 2020 has indeed brought forth unforeseen challenges into the world due to the global coronavirus pandemic. However, this year has also seen monumental victories for psychedelic medicine–a radical new hope for a brighter future. The current state of mental healthcare, which has been starkly exposed due to the pandemic, is seriously insufficient.There is a significant need for new and better mental health treatments now more than ever before. Fortunately, between the groundbreaking clinical research into psychedelic medicine at leading universities and institutions and the ....
Push for Alternative Therapies Prods Researchers Towards Psilocybin FinancialBuzz.com News Commentary NEW YORK, Dec. 15, 2020 /PRNewswire/ The psychedelics market is currently navigating a similar legal situation to the one the cannabis market found itself in for many years. Psychedelics are not legal for recreational use in Canada or the United States, yet medical research on the efficiency of such products may help reduce some of the stigma around them. In fact, some major developments have already begun to change the landscape for the better in this market. For example, earlier in 2019, the state of Colorado became the first state to decriminalize Magic Mushrooms (mushrooms containing psilocybin), taking the substance on a similar path to legalization as that of cannabis. Then, in November 2019, the FDA awarded the second Breakthrough Therapy designation to non-profit Usona Institute, which is studying the effects of psilocybin as an anti-depressant. Currently, despit ....
) (the Company or Havn Life ), a Canadian biotechnology company pursuing standardized extraction of psychoactive compounds, the development of natural healthcare products, is pleased to announce the first preclinical study to focus on the effects of psilocybin on the immune system, in partnership with Dr. Geoffrey Bove, Dr. David Mokler and Susan Chapelle, eMBA. The Company s science division, Havn Research, is undertaking a study to determine if a single dose of psilocybin extract can impact the body s inflammatory response and regulate the human immune system. The Havn Life team will begin this preclinical study in Q1 2021. This study is the first step required to file an application for the development of psilocybin delivery methods that could address inflammatory and immune diseases such as arthritis. ....
Havn Life Sciences Undertakes One of the First Preclinical Studies on Psilocybin and the Immune System albuquerqueexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from albuquerqueexpress.com Daily Mail and Mail on Sunday newspapers.